Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Eurydiki Michalis"'
Autor:
Labrini Papanastasiou, Nikitas Skarakis, Maria Vardaka, Anastasia Dimitriadi, Pinelopi Lampropoulou, Anastasia Perpinia, Eleftherios Vidalakis, Theodosia Choreftaki, Theodoros Marinakis, Theodora Kounadi, Ioannis-Anastasios Vatalas, Eurydiki Michalis
Publikováno v:
Leukemia Research Reports, Vol 17, Iss , Pp 100318- (2022)
We report an extremely rare case of extranodal B-cell NHL: DLBCL (diffuse large B-cell non-Hodgkin lymphoma), stage IVE, presenting with heart and bilateral adrenal involvement. On admission, adrenal and thorax imaging identified large bilateral adre
Externí odkaz:
https://doaj.org/article/c7ad88ba49a242c2bbc17ea803de39ea
Autor:
Evangelos Terpos, Eirini Katodritou, Evangelos Tsiftsakis, Efstathios Kastritis, Dimitrios Christoulas, Anastasia Pouli, Eurydiki Michalis, Evgenia Verrou, Konstantinos Anargyrou, Konstantinos Tsionos, Meletios A. Dimopoulos, Konstantinos Zervas
Publikováno v:
Haematologica, Vol 94, Iss 3 (2009)
Background Renal impairment is a common complication of multiple myeloma. Cystatin-C is considered an accurate marker of glomerular filtration rate in several renal disorders. Microarray analysis has revealed that cystatin-C is one of the most highly
Externí odkaz:
https://doaj.org/article/10944f7fad0344c9ac7200b5bc1d884f
Autor:
Maria Vardaka, Anastasia Dimitriadi, Vatalas Ioannis-Anastasios, Eurydiki Michalis, Athina Markou, Pinelopi Lampropoulou, Theodosia Choreftaki, Anastasia Perpinia, Theodora Kounadi, Eirini Papadimitriou, Konstantinos Lymperopoylos, Spyridon Nikitas Skarakis, Labrini Papanastasiou, Theodoros Marinakis
Publikováno v:
Endocrine Abstracts.
Autor:
Eurydiki Michalis, Magdalini Dadakaridou, Argiris Symeonidis, Theodora Assimakopoulou, Vasiliki Pappa, Gerassimos A. Pangalis, Anastasia Pouli, Christos Georgopoulos, Chrysavgi Lalayanni, Panagiotis Repousis, Christos Poziopoulos, Evangelos Terpos, Panagiotis Zikos, Marie-Christine Kyrtsonis, Ioannis Ntanasis-Stathopoulos, Georgios Vassilopoulos, Maria Gavriatopoulou, Kiki Karvounis-Marolachakis, Helen A. Papadaki, Eirini Katodritou, Emmanouil Spanoudakis, Evdoxia Hatjiharissi
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 1509, p 1509 (2021)
Journal of Clinical Medicine
Volume 10
Issue 7
Journal of Clinical Medicine
Volume 10
Issue 7
The “POWERFUL” multicenter, retrospective, and prospective study investigated the effectiveness of pomalidomide plus low-dose dexamethasone (POM/LoDex) therapy in relapsed/refractory multiple myeloma in routine care in Greece. Ninety-nine eligibl
Autor:
Konstantinos Anargyrou, George Karianakis, Maria Kotsopoulou, Eleftheria Hatzimichael, Pavlina Konstantinidou, Maria Papaioannou, Chryssa Vadikolia, Evangelos Terpos, Katerina Megalakaki, Lydia Kyriazopoulou, Stamatios Karakatsanis, Anna Pigaditou, Theoni Leonidopoulou, Maria Dimou, Eleni Variamis, Michail Michail, Dimitrios Boutsis, Effimia Vrakidou, Gabriella Gainaru, Pantelis Tsirkinidis, Ioannis Kotsianidis, Kostas Konstantopoulos, Paraskevi Roussou, Maria N. Dimopoulou, Maria Palassopoulou, Theodora Assimakopoulou, Panayiotis Tsirigotis, Christina Kalpadakis, Maria K. Angelopoulou, Gerasimos Tsourouflis, Vassiliki Pappa, Evdoxia Hatjiharissi, Sotirios G. Papageorgiou, Theophanis Economopoulos, Themis Karmiris, Argyris Symeonidis, Meletios-Athanasios Dimopoulos, Christos Poziopoulos, Eirini Katodritou, Ekaterini Stefanoudaki, Panayiotis Zikos, Helen A. Papadaki, Marina P. Siakantaris, Theodoros P. Vassilakopoulos, G. Kourti, Maria Tsirogianni, Gerassimos A. Pangalis, Eurydiki Michalis, Panayiotis Panayiotidis, Sotirios Sachanas, Elissavet Vervessou, Marie-Christine Kyrtsonis, Fotios Panitsas
Publikováno v:
Oncologist
Background R-CHOP can cure approximately 75% of patients with primary mediastinal large B-cell lymphoma (PMLBCL), but prognostic factors have not been sufficiently evaluated yet. R-da- EPOCH is potentially more effective but also more toxic than R-CH
Autor:
Eirini Katodritou, Chrystalla Prokopiou, Dimitrios Christoulas, Pavlina Konstantinidou, Efstathios Kastritis, Evlampia Giannopoulou, Marie-Christine Kyrtsonis, Achilles Anagnostopoulos, Chrissa Vadikolia, Nikolaos Giannakoulas, Maria Gavriatopoulou, Chrysanthi Vadikolia, Meletios A. Dimopoulos, Vasiliki Labropoulou, Michalis Michael, Sossana Delimpasi, Christina Kalpadakis, Argiris Symeonidis, Georgia Kaiafa, Eurydiki Michalis, Theodora Gougopoulou, Evgenia Verrou, Maria Kotsopoulou, Evangelos Terpos
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 8, Iss 3, Pp 1-8 (2018)
Blood Cancer Journal, Vol 8, Iss 3, Pp 1-8 (2018)
We have studied the efficacy and the prognostic impact of novel agents in 50 primary plasma cell leukemia (pPCL) patients registered in our database. Eighty percent of patients were treated upfront with novel agent-based combinations; 40% underwent a
Autor:
Anna Christoforidou, Anastasia Pouli, Meletios A. Dimopoulos, Argiris Symeonidis, Theodoros P. Vassilakopoulos, Zafiris Kartasis, Eirini Katodritou, Stavroula Giannouli, Evangelos Terpos, Eurydiki Michalis, Kostas Konstantopoulos, Maria Papaioannou, Kiriaki Kokoviadou, Marie-Christine Kyrtsonis, Catherine Megalakaki, Sosana Delimpasi, Efstathios Kastritis, Dimitra Gika, Flora Zagouri, Athanasios Zomas, Eleftheria Hatzimichael
Publikováno v:
European journal of haematology. 99(5)
Objectives To evaluate the prognostic impact of hypercalcemia in newly diagnosed patients with symptomatic multiple myeloma (MM), especially after the incorporation of new agents. Methods we analyzed the outcomes of newly diagnosed patients with symp
Autor:
Meletios A. Dimopoulos, Maria Gavriatopoulou, Marie-Christine Kyrtsonis, Pierre Morel, Giovanni Palladini, Xavier Leleu, Alessandra Tedeschi, Ramón García-Sanz, Efstathios Kastritis, Eurydiki Michalis, Zafiris Kartasis, Giampaolo Merlini, Dimitra Gika, Pieter Sonneveld
Publikováno v:
Blood, 122(19), 3276-3282. American Society of Hematology
In this phase 2 multicenter trial, we evaluated the activity of bortezomib, dexamethasone, and rituximab (BDR) combination in previously untreated symptomatic patients with Waldenstrom macroglobulinemia (WM). To prevent immunoglobulin M (IgM) "flare,
Autor:
Maria Palassopoulou, Christos A. Apostolopoulos, Nikolaos Harhalakis, Ioannis Batsis, A Spyridonidis, Theodoros P. Vassilakopoulos, Dimitrios Grentzelias, Maria K. Angelopoulou, Ioanna Sakellari, Maria Moschogiannis, Dimitrios Margaritis, Panagiota Giannoulia, Ioannis Apostolidis, Panayiotis Panayiotidis, Panagiotis Tsirigotis, Gerassimos A. Pangalis, Elias Poulakidas, Marie-Christine Kyrtsonis, Achilles Anagnostopoulos, Paraskevi Roussou, Eleutheria Hatzimichael, Zoi Bousiou, Georgios Vassilopoulos, Vasiliki Pappa, Konstantinos Anargyrou, Panagiotis Repousis, Konstantinos Gkirkas, Christina Kalpadakis, Maria Dimou, Eurydiki Michalis
Publikováno v:
Hematological Oncology
This retrospective study aimed to describe the Hellenic experience on the use of brentuximab vedotin (BV) in relapsed/refractory (R/R) Hodgkin lymphoma (HL) given within its indication. From June 2011 to April 2015, ninety‐five patients with R/R HL
Autor:
Constantinos Pamboukas, Sossana Delimpasi, Theofanis Apostolou, Maria Roussou, Efstathios Kastritis, Eurydiki Michalis, Meletios A. Dimopoulos, Evangelos Terpos, Nikitas Nikitas, Georgios Gkortzolidis, Smaragda Marinaki, Ioannis Boletis, Maria Gavriatopoulou
Publikováno v:
Blood. 119:5384-5390
In this phase 1/2 study, we explored the feasibility and activity of an oral regimen of lenalidomide with low-dose dexamethasone and low-dose oral cyclophosphamide (RdC) in patients with primary systemic light chain amyloidosis. RdC was given for up